套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-009217 Size: 31 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-20-009215 Size: 10 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-144122 Act: 34 Size: 177 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012198 Size: 34 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012176 Size: 31 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012177 Size: 11 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012179 Size: 101 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012168 Size: 111 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012170 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012172 Size: 91 KB 网页链接